H15.003 Unspecified scleritis, bilateral

Name of the Condition

• Unspecified Scleritis, Bilateral
• Medical Term: Scleritis
• ICD Code: H15.003

Summary

Unspecified scleritis, bilateral, is an inflammatory condition affecting the sclera, the tough, white outer layer of both eyeballs. It can cause significant eye pain and may lead to vision-threatening complications if not managed appropriately. The condition often requires prompt evaluation and treatment to prevent long-term damage.

Causes

Scleritis may result from autoimmune disorders, infections, or systemic inflammatory diseases. Autoimmune conditions such as rheumatoid arthritis, lupus, or granulomatosis with polyangiitis are common underlying causes. Infections like herpes zoster or syphilis, as well as trauma or surgery, can also trigger scleral inflammation. In some cases, the cause remains idiopathic.

Risk Factors

• Autoimmune diseases (e.g., rheumatoid arthritis, lupus)
• Systemic inflammatory conditions (e.g., vasculitis)
• History of eye trauma or surgery
• Age-related changes in scleral tissue
• Exposure to infectious agents

Symptoms

• Severe, deep eye pain, often described as aching or throbbing
• Redness, typically localized to the sclera
• Blurred vision or reduced visual acuity
• Sensitivity to light (photophobia)
• Tearing or discharge
• Possible swelling of the eyelids

Diagnosis

Diagnosis involves a comprehensive eye examination, including slit-lamp biomicroscopy to assess scleral inflammation. Additional tests may include visual acuity testing, intraocular pressure measurement, and imaging studies (e.g., ultrasound or MRI) to evaluate the extent of inflammation. Laboratory tests, such as blood work or serology, may be performed to identify underlying systemic causes.

Treatment Options

Treatment depends on the severity and underlying cause. Mild cases may be managed with topical or oral anti-inflammatory medications, such as corticosteroids. Severe or refractory cases may require immunosuppressive therapy. Infections, if present, are treated with appropriate antimicrobial agents. Pain management and supportive care, including lubricating eye drops, may also be recommended.

Prognosis and Follow-Up

Prognosis varies based on the underlying cause and timeliness of treatment. Early intervention can reduce the risk of vision loss, but severe or untreated cases may lead to complications like corneal thinning, cataracts, or glaucoma. Regular follow-up with an ophthalmologist is essential to monitor for recurrence or progression.

Complications

• Vision loss or permanent visual impairment
• Corneal perforation or thinning
• Cataracts
• Glaucoma
• Systemic complications if related to underlying autoimmune or infectious disease

Lifestyle & Prevention

• Avoid eye trauma or injury
• Manage underlying autoimmune or inflammatory conditions with medical supervision
• Use protective eyewear in high-risk environments
• Seek prompt care for eye pain or redness to prevent progression

When to Seek Professional Help

Seek immediate medical attention if experiencing severe eye pain, sudden vision changes, or persistent redness. Early evaluation is critical to prevent vision-threatening complications.

Tips for Medical Coders

Document the bilateral nature of the condition clearly in the medical record. Ensure the code H15.003 is used when the scleritis is unspecified and affects both eyes. Verify that no laterality (e.g., right or left) is specified, as this would require a different code.